DK138644B - Analogifremgangsmåde til fremstilling af 1-aryl-N-dialkylaminoalkyl-3,4-dihydro-2(1H)-isoquinolincarboxamider eller deres farmaceutisk acceptable syreadditionssalte eller kvaternære ammoniumsalte. - Google Patents

Analogifremgangsmåde til fremstilling af 1-aryl-N-dialkylaminoalkyl-3,4-dihydro-2(1H)-isoquinolincarboxamider eller deres farmaceutisk acceptable syreadditionssalte eller kvaternære ammoniumsalte.

Info

Publication number
DK138644B
DK138644B DK395174AA DK395174A DK138644B DK 138644 B DK138644 B DK 138644B DK 395174A A DK395174A A DK 395174AA DK 395174 A DK395174 A DK 395174A DK 138644 B DK138644 B DK 138644B
Authority
DK
Denmark
Prior art keywords
dialkylaminoalkyl
dihydro
aryl
preparation
pharmaceutically acceptable
Prior art date
Application number
DK395174AA
Other languages
Danish (da)
English (en)
Other versions
DK395174A (de
DK138644C (de
Inventor
Peter K Yonan
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of DK395174A publication Critical patent/DK395174A/da
Publication of DK138644B publication Critical patent/DK138644B/da
Application granted granted Critical
Publication of DK138644C publication Critical patent/DK138644C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/52Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK395174AA 1973-07-23 1974-07-22 Analogifremgangsmåde til fremstilling af 1-aryl-N-dialkylaminoalkyl-3,4-dihydro-2(1H)-isoquinolincarboxamider eller deres farmaceutisk acceptable syreadditionssalte eller kvaternære ammoniumsalte. DK138644B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US381505A US3905982A (en) 1973-07-23 1973-07-23 1-Aryl-n-dialkylaminoalkyl-3,4-dihydro-2(1H)-isoquinolinecarboxamides and related compounds

Publications (3)

Publication Number Publication Date
DK395174A DK395174A (de) 1975-03-10
DK138644B true DK138644B (da) 1978-10-09
DK138644C DK138644C (de) 1979-03-19

Family

ID=23505299

Family Applications (1)

Application Number Title Priority Date Filing Date
DK395174AA DK138644B (da) 1973-07-23 1974-07-22 Analogifremgangsmåde til fremstilling af 1-aryl-N-dialkylaminoalkyl-3,4-dihydro-2(1H)-isoquinolincarboxamider eller deres farmaceutisk acceptable syreadditionssalte eller kvaternære ammoniumsalte.

Country Status (17)

Country Link
US (1) US3905982A (de)
JP (1) JPS5041873A (de)
AR (2) AR202416A1 (de)
AT (1) AT329563B (de)
BE (1) BE817917A (de)
CA (1) CA1041501A (de)
CH (2) CH605774A5 (de)
DE (1) DE2435168A1 (de)
DK (1) DK138644B (de)
ES (2) ES428503A1 (de)
FR (1) FR2238488B1 (de)
GB (1) GB1452398A (de)
IE (1) IE39630B1 (de)
NL (1) NL7409881A (de)
NO (1) NO141160C (de)
SE (1) SE387341B (de)
ZA (1) ZA744665B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8518634D0 (en) * 1985-07-23 1985-08-29 Smithkline Beckman Corp Chemical compounds
DK8386A (da) * 1986-01-15 1987-07-09 Tpo Pharmachim Nye n-substituerede 1-benzyl-2-carbamoyltetrahydroisoquinoliner og fremgangsmaade til fremstilling af samme
JP2577215B2 (ja) * 1987-01-16 1997-01-29 化研生薬株式会社 ベンジルイソキノリン誘導体
US6376670B1 (en) 1997-06-19 2002-04-23 Sepracor Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
JP2002505689A (ja) 1997-06-19 2002-02-19 セプレイコー インコーポレイテッド キノリン−インドール抗菌剤、それらに関する用途及び組成物
US6858147B2 (en) * 2001-08-03 2005-02-22 Dispersion Technology, Inc. Method for the removal of heavy metals from aqueous solution by means of silica as an adsorbent in counter-flow selective dialysis
US20060229524A1 (en) * 2005-04-08 2006-10-12 Alden Ozment Method for the accurate placement of EKG electrodes
EP3763711A1 (de) * 2019-07-09 2021-01-13 Allinky Biopharma Tetrahydroisochinolinverbindungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3524858A (en) * 1967-05-18 1970-08-18 Warner Lambert Pharmaceutical 1,4 - dihydro-1-substituted alkyl-6,7-methylenedioxy - 4 - oxoquinoline-3-carboxylic acid
US3483206A (en) * 1967-12-15 1969-12-09 Ciba Geigy Corp N-isoquinolylalkanoyl-n-arylamines
US3634429A (en) * 1969-09-30 1972-01-11 Hoffmann La Roche Morphinan derivatives and preparation thereof
US3666763A (en) * 1970-01-06 1972-05-30 Hoffmann La Roche 4-phenyl isoquinolines and process for preparing same

Also Published As

Publication number Publication date
DK395174A (de) 1975-03-10
AR202416A1 (es) 1975-06-06
BE817917A (fr) 1975-01-22
US3905982A (en) 1975-09-16
JPS5041873A (de) 1975-04-16
FR2238488B1 (de) 1978-06-30
AR205380A1 (es) 1976-04-30
ES428503A1 (es) 1976-12-16
SE387341B (sv) 1976-09-06
ATA602874A (de) 1975-08-15
CA1041501A (en) 1978-10-31
ZA744665B (en) 1975-09-24
CH605774A5 (de) 1978-10-13
SE7409496L (de) 1975-01-24
CH605773A5 (de) 1978-10-13
AU7147074A (en) 1976-01-22
DE2435168A1 (de) 1975-02-06
NO141160B (no) 1979-10-15
DK138644C (de) 1979-03-19
GB1452398A (en) 1976-10-13
AT329563B (de) 1976-05-25
IE39630L (en) 1975-01-23
FR2238488A1 (de) 1975-02-21
NO141160C (no) 1980-01-23
ES448973A1 (es) 1977-11-16
NL7409881A (nl) 1975-01-27
NO742679L (de) 1975-01-24
IE39630B1 (en) 1978-11-22

Similar Documents

Publication Publication Date Title
DK136651B (da) Analogifremgangsmåde til fremstilling af pyridinderivater, deres syreadditionssalte eller deres kvaternære ammoniumforbindelser.
DK138644B (da) Analogifremgangsmåde til fremstilling af 1-aryl-N-dialkylaminoalkyl-3,4-dihydro-2(1H)-isoquinolincarboxamider eller deres farmaceutisk acceptable syreadditionssalte eller kvaternære ammoniumsalte.
DK139358B (da) Analogifremgangsmåde til fremstilling af vincaminderivater eller syreadditionssalte deraf.
DK136713B (da) Analogifremgangsmåde til fremstilling af alfa-aryl-4-substituerede piperidinoalkanolderivater eller deres syreadditionssalte.
DK137534B (da) Fremgangsmåde til fremstilling af 3,4-dihydro-2(1H)-quinazolinonderivater.
DK133899B (da) Analogifremgangsmåde til fremstilling af benzofuranderivater eller farmaceutisk acceptable syreadditionssalte deraf.
DK138893B (da) Analogifremgangsmåde til fremstilling af 1-(indolyl-3-alkyl)-4-ureido-piperidiner eller -thioureido-piperidiner eller syreadditionssalte deraf.
DK138536B (da) Analogifremgangsmåde til fremstilling af 1-naphthalen- eller 4-quinolincarboxamider eller farmaceutisk acceptable syreadditionssalte deraf.
DK131373B (da) Analogifremgangsmåde til fremstilling af 3,4-dihydroisoquinoleinderivater eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK131148B (da) Analogifremgangsmåde til fremstilling af derivater af phenanthridin eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK137085B (da) Analogifremgangsmåde til fremstilling af cycloalkyl-alkyl-estere af vincaminsyrederivater eller syreadditionssalte deraf.
DK136816B (da) Analogifremgangsmåde til fremstilling af phenoxypropylaminderivater eller af deres salte.
DK123031B (da) Analogifremgangsmåde til fremstilling af derivater af 1-benzyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolin eller syreadditionssalte deraf.
DK109141C (da) Fremgangsmåde til fremstilling af substituerede 2-hydroxy-hexahydro-11bH-benzo[a]quinoliziner, estere deraf eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK138265B (da) Analogifremgangsmåde til fremstilling af 4,4-diaryl-2-hydroxybutylaminer eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK131030B (da) Fremgangsmåde til fremstilling af N-diethylaminoethyl-2-methoxy-4-amino-5-chlorbenzamid eller syreadditionssalte eller kvaternære ammoniumsalte heraf.
DK134434B (da) Analogifremgangsmåde til fremstilling af cis-A-decahydro-5-phenyl-4,1-benzoxazepiner eller syreadditionssalte, kvaternære ammoniumsalte eller N-oxider deraf.
DK134233B (da) Analogifremgangsmåde til fremstilling af substituerede benzimidazolinoner eller triazaspiro-/4,5/-decan-4-oner eller syreadditionssalte deraf.
DK135574B (da) Fremgangsmåde til fremstilling af benzylaminderivater eller fysiologisk anvendelige syreadditionssalte heraf.
DK140259B (da) Analogifremgangsmåde til fremstilling af 1-(L-(-)-omega-amino-alfa-hydroxyalkanoyl)-kanamyciner eller syreadditionssalte deraf.
DK137083B (da) Fremgangsmåde til fremstilling af 1,4-disubstituerede 2(1H)-quinazolinonderivater eller syreadditionssalte deraf.
DK140431B (da) Analogifremgangsmåde til fremstilling af et N2-dansyl-L-arginin-derivat eller syreadditionssalte deraf.
DK124123B (da) Analogifremgangsmåde til fremstilling af dibenz[a,d]-5H-cycloheptenderivater eller syreadditionssalte deraf.
DK138320B (da) Analogifremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller farmaceutisk anvendelige syreadditionssalte deraf.
DK124755B (da) Analogifremgangsmåde til fremstilling af 2,3-disubstituerede quinazolin-4-on-derivater eller syreadditionssalte eller kvaternære ammoniumderivater deraf.